|Articles|November 15, 2019
The Ins and Outs of Incorporating Patient Centricity in Drug Development
Author(s)Parexel
Trending on PharmExec
1
The Evolving Relationship Between FDA and Biotech
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
4
The Implications of GLP-1s Replacing Oncology as the Key Value Driver
5